X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lopinavir/ritonavir (204) 204
humans (145) 145
life sciences & biomedicine (144) 144
science & technology (144) 144
lopinavir (137) 137
hiv infections - drug therapy (117) 117
female (96) 96
male (93) 93
ritonavir (80) 80
infectious diseases (77) 77
adult (76) 76
hiv (73) 73
ritonavir - therapeutic use (72) 72
pharmacology & pharmacy (69) 69
ritonavir - administration & dosage (56) 56
middle aged (50) 50
immunology (46) 46
hiv protease inhibitors - therapeutic use (44) 44
ritonavir - adverse effects (44) 44
pyrimidinones - therapeutic use (41) 41
treatment outcome (39) 39
viral load (38) 38
drug therapy, combination (37) 37
covid-19 (36) 36
pyrimidinones - administration & dosage (35) 35
anti-hiv agents - therapeutic use (34) 34
drug combinations (34) 34
aids/hiv (33) 33
pyrimidinones - adverse effects (32) 32
ritonavir - pharmacokinetics (32) 32
antiviral agents (31) 31
lopinavir-ritonavir (30) 30
anti-hiv agents - administration & dosage (29) 29
antiretroviral therapy (29) 29
hiv protease inhibitors - administration & dosage (29) 29
lopinavir - therapeutic use (29) 29
efavirenz (28) 28
hiv infection (28) 28
hiv infections - virology (28) 28
children (27) 27
hiv protease inhibitors - pharmacokinetics (27) 27
hiv-1 (27) 27
cd4 lymphocyte count (26) 26
hiv protease inhibitors - adverse effects (26) 26
pharmacokinetics (26) 26
lopinavir - administration & dosage (23) 23
pyrimidinones - pharmacokinetics (23) 23
drug administration schedule (21) 21
drug interactions (21) 21
highly active antiretroviral therapy (21) 21
hiv-1 - drug effects (21) 21
medicine & public health (21) 21
virology (21) 21
antiretroviral therapy, highly active (20) 20
monotherapy (20) 20
pharmacology/toxicology (20) 20
adolescent (19) 19
human immunodeficiency virus--hiv (19) 19
hydroxychloroquine (19) 19
protease inhibitors (19) 19
anti-hiv agents - adverse effects (18) 18
drug therapy (18) 18
health aspects (18) 18
child (17) 17
microbiology (17) 17
pediatrics (17) 17
prospective studies (17) 17
ritonavir - pharmacology (17) 17
anti-hiv agents - pharmacokinetics (16) 16
dosage and administration (16) 16
infant (16) 16
lopinavir/ritonavir, adverse reactions (16) 16
sars-cov-2 (16) 16
analysis (15) 15
anti-hiv agents (15) 15
hiv infections - complications (15) 15
protease inhibitor (15) 15
remdesivir (15) 15
young adult (15) 15
antiretroviral drugs (14) 14
antiretroviral therapy, highly active - adverse effects (14) 14
child, preschool (14) 14
lopinavir - adverse effects (14) 14
patients (14) 14
research (14) 14
risk factors (14) 14
rna, viral - blood (14) 14
antiretroviral therapy, highly active - methods (13) 13
area under curve (13) 13
chloroquine (13) 13
hiv infections - metabolism (13) 13
lopinavir - pharmacokinetics (13) 13
pilot projects (13) 13
antiretrovirals (12) 12
drug resistance, viral (12) 12
hiv infections (12) 12
hiv protease inhibitors - pharmacology (12) 12
hiv-1 - genetics (12) 12
lopinavir/ritonavir, therapeutic use (12) 12
nevirapine (12) 12
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (268) 268
Spanish (22) 22
Chinese (7) 7
French (4) 4
Russian (4) 4
Japanese (3) 3
Portuguese (2) 2
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical infectious diseases, ISSN 1058-4838, 07/2016, Volume 63, Issue 2, pp. 268 - 280
Journal Article
Enfermedades infecciosas y microbiología clínica, ISSN 0213-005X, 11/2014, Volume 32, Issue 3, pp. 7 - 11
According to evidence from randomized controlled trials and epidemiological data, the antiretroviral treatment (ART) of choice has consisted of the combination... 
Lopinavir/ritonavir | Dual therapy | New strategies
Journal Article
Enfermedades infecciosas y microbiología clínica, ISSN 0213-005X, 11/2014, Volume 32, Issue 3, pp. 12 - 17
Interest in simplification arises from the need to dispense with nucleoside analogs due to their long-term toxicity. Since the first trials analyzing the... 
Dual therapy | Simplification | HIV | Lopinavir/ritonavir | Monotherapy
Journal Article
Enfermedades infecciosas y microbiología clínica, ISSN 0213-005X, 11/2014, Volume 32, Issue 3, pp. 22 - 25
There are clear sex-related biological differences between men and women. Diseases that affect the two sexes differently are studied separately. However, some... 
Women | HIV | Lopinavir/ritonavir | Antiretroviral therapy
Journal Article
Enfermedades infecciosas y microbiología clínica, ISSN 0213-005X, 11/2014, Volume 32, Issue 3, pp. 31 - 34
Lopinavir/ritonavir (LPV/r) was approved for use in the treatment of human immunodeficiency virus (HIV) infection in 2001 and is the protease inhibitor that... 
Lopinavir/ritonavir | HIV infection | Antiretroviral therapy
Journal Article
Journal of neurovirology, ISSN 1538-2443, 09/2015, Volume 22, Issue 2, pp. 170 - 178
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 2008, Volume 68, Issue 5, pp. 567 - 578
Journal Article
Journal of microbiology, immunology and infection, ISSN 1684-1182, 10/2020, Volume 53, Issue 5, pp. 674 - 675
Covid-19 infection caused by the novel coronavirus SARS-COV-2 continues to be a major global health challenge. Till date, no drug has been approved for the... 
COVID-19 | Lopinavir-ritonavir | Index Medicus
Journal Article
Journal Article
Journal Article
Frontiers in pharmacology, ISSN 1663-9812, 12/2019, Volume 10, pp. 1455 - 1455
The World Health Organization guidelines recommend lopinavir/ritonavir (LPV/r) as a second-line antiretroviral therapy (ART) for HIV-infected adults in... 
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | lopinavir/ritonavir | human immunodeficiency virus | second-line antiretroviral therapy | ART-experienced | efficacy and safety
Journal Article